Endurance Wealth Management, Inc. Immunic, Inc. Transaction History

Endurance Wealth Management, Inc.

  • $731 Million
  • Q2 2023

A detailed history of Endurance Wealth Management, Inc. transactions in Immunic, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 500 shares of IMUX stock, worth $525. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$525
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 27, 2020
SELL
$11.74 - $22.0 $5,870 - $11,000
-500 Reduced 50.0%
500 $12,000
Q2 2020

Jul 14, 2020
BUY
$5.67 - $15.86 $5,670 - $15,860
1,000 New
1,000 $12,000

Others Institutions Holding IMUX

# of Institutions
75
Shares Held
51.2M
Call Options Held
824K
Put Options Held
354K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $32.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Endurance Wealth Management, Inc. Portfolio

Follow Endurance Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email